- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Alpha Tau Medical Ltd.: Alpha Tau Announces Upcoming Presentation of New Data at 2025 ASCO GI Symposium and at Company R&D Update Day | 3 | GlobeNewswire (USA) | ||
| Di | Alpha Tau Medical Ltd.: Alpha Tau Announces Appointment of Maya Netser to its Board of Directors; Board Member Meir Jakobsohn Stepping Down, Staying on as Advisor | 1 | GlobeNewswire (USA) | ||
| Di | Alpha Tau Medical Ltd. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 06.12. | Alpha Tau Medical Ltd.: Alpha Tau to Participate in Ladenburg's Oncology Innovators & Investors Symposium | 1 | GlobeNewswire (USA) | ||
| 06.12. | Alpha Tau Medical Ltd. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 19.11. | Alpha Tau Medical GAAP EPS of -$0.32 | 5 | Seeking Alpha | ||
| 19.11. | Alpha Tau Medical Ltd.: Alpha Tau Medical Announces Third Quarter 2024 Financial Results and Provides Corporate Update | 29 | GlobeNewswire (Europe) | - Alpha DaRT® accepted into the prestigious Total Product Life Cycle Advisory Program (TAP) of the FDA, to accelerate market access to the Alpha DaRT® for patients with recurrent glioblastoma multiforme... ► Artikel lesen | |
| ALPHA TAU MEDICAL Aktie jetzt für 0€ handeln | |||||
| 13.11. | Alpha Tau Medical Ltd. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 21.10. | Alpha Tau Medical Ltd.: Alpha Tau Announces Acceptance Into FDA's Total Product Life Cycle Advisory Program to Accelerate Market Access to Alpha DaRT for Patients with Recurrent Glioblastoma Multiforme | 91 | GlobeNewswire (Europe) | JERUSALEM, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the "Company") (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-emitters cancer therapy Alpha DaRT®... ► Artikel lesen | |
| 21.10. | Alpha Tau Medical Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 11.10. | Alpha Tau Medical-Aktien behalten Buy-Rating von H.C. Wainwright | 1 | Investing.com Deutsch | ||
| 11.10. | Alpha Tau Medical shares maintain Buy rating from H.C. Wainwright | 1 | Investing.com | ||
| 10.10. | Alpha Tau Medical Ltd.: Alpha Tau Treats First Patient with Recurrent Lung Cancer | 1 | GlobeNewswire (USA) | ||
| 10.10. | Alpha Tau Medical Ltd. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 20.09. | Alpha Tau Medical Ltd.: Alpha Tau Announces FDA Approval of IDE to Initiate Multi-Center Investigator-Initiated Study of Alpha DaRT in Immunocompromised Patients with Recurrent cSCC | 99 | GlobeNewswire (Europe) | JERUSALEM, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the "Company") (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT®... ► Artikel lesen | |
| 20.09. | Alpha Tau Medical Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 22.08. | Alpha Tau Medical Ltd.: Alpha Tau to Participate in the H.C. Wainwright 26th Annual Global Investment Conference, the Sidoti Small-Cap Virtual Investor Conference, the Redburn Atlantic and Rothschild & Co 2024 Radiopharma Conference, and the ... | 1 | GlobeNewswire (USA) | ||
| 22.08. | Alpha Tau Medical Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 21.08. | Alpha Tau Medical stock holds Buy rating on clinical trial updates | 1 | Investing.com | ||
| 14.08. | Alpha Tau Medical Ltd.: Alpha Tau Medical Announces Second Quarter 2024 Financial Results and Provides Corporate Update | 216 | GlobeNewswire (Europe) | - First patient treated in May for liver metastases from colorectal cancer - - Publication in June in Cancers journal of long-term safety and efficacy data in multiple hard-to-treat superficial cancers... ► Artikel lesen |
Seite:
1 2 Weiter >>
26 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| EMEIS | 5,162 | +1,04 % | emeis announces €251m in disposals of real estate and operating assets since the beginning of October | Nearly €900 million in disposals completed since mid-2022 or secured to date Disposal of activities in Chile and the Czech Republic
Regulatory News:
emeis (Paris:EMEIS) today announced... ► Artikel lesen | |
| NANO-X IMAGING | 6,770 | +3,04 % | Nano-X Imaging LTD.: Nanox.ARC Imaging System Receives FDA Clearance for General Use, Including Pulmonary Indication | Nanox.ARC receives additional FDA clearance to produce tomographic images for general use, including pulmonary, intra-abdominal and paranasal indications, in addition to its previously cleared indication... ► Artikel lesen | |
| BUTTERFLY NETWORK | 3,075 | +3,71 % | Butterfly Network (NYSE:BFLY) Shares Down 6.3% - What's Next? | ||
| CARMAT | 0,960 | -0,52 % | Successful first "Aeson European User Meeting", marking an important step in the deployment of CARMAT's artificial heart | More than 100 healthcare professionals from 41 hospitals and 10 countries rallied to share their experiences of the Aeson® artificial heart All hospitals taking part in the event confirmed... ► Artikel lesen | |
| GOODRX | 4,450 | -0,89 % | GoodRx stock rises 5% after new CEO appointment | ||
| TALKSPACE | 2,985 | -0,83 % | Espresa Partners with Talkspace to Boost Employee Well-Being with Accessible Mental Health Benefits | Espresa has partnered with Talkspace to expand mental health support for employees. Through Espresa's platform, clients now have access to Talkspace's 5,000+ licensed therapists, offering secure, on-demand... ► Artikel lesen | |
| JOINT CORP | 10,300 | +0,10 % | The Joint Corp. Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | SCOTTSDALE, Ariz., Oct. 15, 2024 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT) ("The Joint or "the Company"), the nation's largest franchisor of chiropractic care through The Joint Chiropractic®... ► Artikel lesen | |
| MIMEDX | 9,110 | +0,33 % | MiMedx Group, Inc: MIMEDX Files Patent Infringement Lawsuit Against Surgenex | ||
| PROCEPT BIOROBOTICS | 81,25 | +0,58 % | PROCEPT BioRobotics Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance | SAN JOSE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| HYPERFINE | 0,885 | -4,73 % | Hyperfine, Inc.: Hyperfine Expands Global Market Reach with New Distribution Partnerships in European and Middle Eastern Markets | Strategic agreements set the stage for further global adoption of portable MR brain imaging technology, fueling expansion plans for 2025.
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health... ► Artikel lesen | |
| ATRICURE | 30,725 | +2,25 % | Pre-market Movers: ASP Isotopes, NerdWallet, Reddit, AtriCure, Qorvo | OLATHE (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.05 A.M. ET).In the Green ASP Isotopes Inc. (ASPI) is up over 44% at $8.33.
NerdWallet... ► Artikel lesen | |
| BIOMERICA | 0,275 | +3,46 % | BIOMERICA INC - S-8, Securities to be offered to employees in employee benefit plans | ||
| PROGYNY | 14,350 | +1,13 % | Progyny, Inc. Announces Third Quarter 2024 Results | Sales Season Yields Over 80 New Clients, 1.1 Million New Covered LivesSelected by a Leading National Health Plan and a Regional Health Plan as Their Preferred Partner1.5 Million Lives Adopt Newest... ► Artikel lesen | |
| PROPHASE LABS | 0,630 | -3,54 % | ProPhase Labs stock hits 52-week low at $0.64 amid sharp decline | ||
| AMWELL | 7,860 | +0,38 % | Amwell CFO Mark Hirschhorn takes on expanded role as COO |
ALPHA TAU MEDICAL LTD gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell -0,64 % bei einem Aktienkurs von 3,100 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ALPHA TAU MEDICAL LTD finden Sie auf Wallstreet Online.
